Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.
Grobben M, van der Straten K, Brouwer PJ, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, Appelman B, Lavell AA, van Vught LA, Burger JA, Poniman M, Oomen M, Eggink D, Bijl TP, van Willigen HD, Wynberg E, Verkaik BJ, Figaroa OJ, de Vries PJ, Boertien TM; Amsterdam UMC COVID-19 S3/HCW study group; Bomers MK, Sikkens JJ, Le Grand R, de Jong MD, Prins M, Chung AW, de Bree GJ, Sanders RW, van Gils MJ. Grobben M, et al. Among authors: oomen m. Elife. 2021 Nov 23;10:e70330. doi: 10.7554/eLife.70330. Elife. 2021. PMID: 34812143 Free PMC article.
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination.
Caniels TG, Bontjer I, van der Straten K, Poniman M, Burger JA, Appelman B, Lavell AHA, Oomen M, Godeke GJ, Valle C, Mögling R, van Willigen HDG, Wynberg E, Schinkel M, van Vught LA, Guerra D, Snitselaar JL, Chaturbhuj DN, Cuella Martin I; Amsterdam UMC COVID-19 S3/HCW study group; Moore JP, de Jong MD, Reusken C, Sikkens JJ, Bomers MK, de Bree GJ, van Gils MJ, Eggink D, Sanders RW. Caniels TG, et al. Among authors: oomen m. Sci Adv. 2021 Sep 3;7(36):eabj5365. doi: 10.1126/sciadv.abj5365. Epub 2021 Sep 3. Sci Adv. 2021. PMID: 34516917 Free PMC article.
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination.
Appelman B, van der Straten K, Lavell AHA, Schinkel M, Slim MA, Poniman M, Burger JA, Oomen M, Tejjani K, Vlaar APJ, Wiersinga WJ, Smulders YM, van Vught LA, Sanders RW, van Gils MJ, Bomers MK, Sikkens JJ; Amsterdam UMC COVID-19 S3/HCW study group. Appelman B, et al. Among authors: oomen m. EBioMedicine. 2021 Oct;72:103589. doi: 10.1016/j.ebiom.2021.103589. Epub 2021 Sep 24. EBioMedicine. 2021. PMID: 34571363 Free PMC article.
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern.
Brinkkemper M, Brouwer PJM, Maisonnasse P, Grobben M, Caniels TG, Poniman M, Burger JA, Bontjer I, Oomen M, Bouhuijs JH, van der Linden CA, Villaudy J, van der Velden YU, Sliepen K, van Gils MJ, Le Grand R, Sanders RW. Brinkkemper M, et al. Among authors: oomen m. NPJ Vaccines. 2021 Dec 3;6(1):146. doi: 10.1038/s41541-021-00411-7. NPJ Vaccines. 2021. PMID: 34862406 Free PMC article.
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
van Gils MJ, van Willigen HDG, Wynberg E, Han AX, van der Straten K, Burger JA, Poniman M, Oomen M, Tejjani K, Bouhuijs JH, Verveen A, Lebbink R, Dijkstra M, Appelman B, Lavell AHA, Caniels TG, Bontjer I, van Vught LA, Vlaar APJ, Sikkens JJ, Bomers MK, Russell CA, Kootstra NA, Sanders RW, Prins M, de Bree GJ, de Jong MD; RECoVERED Study Group. van Gils MJ, et al. Among authors: oomen m. Cell Rep Med. 2021 Dec 14;3(1):100486. doi: 10.1016/j.xcrm.2021.100486. eCollection 2022 Jan 18. Cell Rep Med. 2021. PMID: 35103254 Free PMC article.
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
van Gils MJ, Lavell A, van der Straten K, Appelman B, Bontjer I, Poniman M, Burger JA, Oomen M, Bouhuijs JH, van Vught LA, Slim MA, Schinkel M, Wynberg E, van Willigen HDG, Grobben M, Tejjani K, van Rijswijk J, Snitselaar JL, Caniels TG; Amsterdam UMC COVID-19 S3/HCW study group; Vlaar APJ, Prins M, de Jong MD, de Bree GJ, Sikkens JJ, Bomers MK, Sanders RW. van Gils MJ, et al. Among authors: oomen m. PLoS Med. 2022 May 17;19(5):e1003991. doi: 10.1371/journal.pmed.1003991. eCollection 2022 May. PLoS Med. 2022. PMID: 35580156 Free PMC article.
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection.
Lavell AHA, Sikkens JJ, Edridge AWD, van der Straten K, Sechan F, Oomen M, Buis DTP, Schinkel M, Burger JA, Poniman M, van Rijswijk J, de Jong MD, de Bree GJ, Peters EJG, Smulders YM, Sanders RW, van Gils MJ, van der Hoek L, Bomers MK. Lavell AHA, et al. Among authors: oomen m. iScience. 2022 Oct 21;25(10):105105. doi: 10.1016/j.isci.2022.105105. Epub 2022 Sep 9. iScience. 2022. PMID: 36101832 Free PMC article.
Saliva SARS-CoV-2 Antibody Prevalence in Children.
Keuning MW, Grobben M, de Groen AC, Berman-de Jong EP, Bijlsma MW, Cohen S, Felderhof M, de Groof F, Molanus D, Oeij N, Rijpert M, van Eijk HWM, Koen G, van der Straten K, Oomen M, Visser R, Linty F, Steenhuis M, Vidarsson G, Rispens T, Plötz FB, van Gils MJ, Pajkrt D. Keuning MW, et al. Among authors: oomen m. Microbiol Spectr. 2021 Oct 31;9(2):e0073121. doi: 10.1128/Spectrum.00731-21. Epub 2021 Sep 15. Microbiol Spectr. 2021. PMID: 34523985 Free PMC article.
Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands.
Juncker HG, Mulleners SJ, Ruhé EJM, Coenen ERM, Bakker S, van Doesburg M, Harinck JE, Rood RD, Bouhuijs JH, Oomen M, de Groot PCJM, Pajkrt PD, Korosi A, van Goudoever PJB, van Gils MJ, van Keulen BJ. Juncker HG, et al. Among authors: oomen m. EClinicalMedicine. 2022 May;47:101393. doi: 10.1016/j.eclinm.2022.101393. Epub 2022 Apr 18. EClinicalMedicine. 2022. PMID: 35465077 Free PMC article.
89 results